These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 12050101

  • 1. Her-2/neu gene amplification in ductal carcinoma in situ of the breast.
    Hoque A, Sneige N, Sahin AA, Menter DG, Bacus JW, Hortobagyi GN, Lippman SM.
    Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):587-90. PubMed ID: 12050101
    [Abstract] [Full Text] [Related]

  • 2. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
    Xu R, Perle MA, Inghirami G, Chan W, Delgado Y, Feiner H.
    Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
    [Abstract] [Full Text] [Related]

  • 3. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
    Latta EK, Tjan S, Parkes RK, O'Malley FP.
    Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
    [Abstract] [Full Text] [Related]

  • 4. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma.
    Ariga R, Zarif A, Korasick J, Reddy V, Siziopikou K, Gattuso P.
    Breast J; 2005 Dec; 11(4):278-80. PubMed ID: 15982396
    [Abstract] [Full Text] [Related]

  • 5. HER2/neu amplification in breast cancer: stratification by tumor type and grade.
    Hoff ER, Tubbs RR, Myles JL, Procop GW.
    Am J Clin Pathol; 2002 Jun; 117(6):916-21. PubMed ID: 12047143
    [Abstract] [Full Text] [Related]

  • 6. Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies.
    Moinfar F, Okcu M, Tsybrovskyy O, Regitnig P, Lax SF, Weybora W, Ratschek M, Tavassoli FA, Denk H.
    Cancer; 2003 Aug 15; 98(4):703-11. PubMed ID: 12910513
    [Abstract] [Full Text] [Related]

  • 7. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR, Abd-Elwahed SR, Abdulwahed AR.
    Cell Biol Int; 2008 Jun 15; 32(6):698-707. PubMed ID: 18296077
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of HER-2/neu expression in patients with ductal carcinoma in situ.
    Stackievicz R, Paran H, Bernheim J, Shapira M, Weisenberg N, Kaufman T, Klein E, Gutman M.
    Isr Med Assoc J; 2010 May 15; 12(5):290-5. PubMed ID: 20929083
    [Abstract] [Full Text] [Related]

  • 9. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL.
    APMIS Suppl; 2003 May 15; (108):1-67. PubMed ID: 12874968
    [Abstract] [Full Text] [Related]

  • 10. Risk of breast cancer according to the status of HER-2/neu oncogene amplification.
    Huang WY, Newman B, Millikan RC, Conway K, Hulka BS, Schell MJ, Liu ET.
    Cancer Epidemiol Biomarkers Prev; 2000 Jan 15; 9(1):65-71. PubMed ID: 10667465
    [Abstract] [Full Text] [Related]

  • 11. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
    Mylonas I, Makovitzky J, Jeschke U, Briese V, Friese K, Gerber B.
    Anticancer Res; 2005 Jan 15; 25(3A):1719-23. PubMed ID: 16033090
    [Abstract] [Full Text] [Related]

  • 12. Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women.
    Rodrigues NA, Dillon D, Carter D, Parisot N, Haffty BG.
    Cancer; 2003 Mar 15; 97(6):1393-403. PubMed ID: 12627502
    [Abstract] [Full Text] [Related]

  • 13. C-KIT expression in ductal carcinoma in situ of the breast: co-expression with HER-2/neu.
    Diallo R, Rody A, Jackisch C, Ting E, Schaefer KL, Kissler S, Karn T, Geddert H, Engels K, Kaufmann M, Gabbert HE, Shroyer KR, Poremba C.
    Hum Pathol; 2006 Feb 15; 37(2):205-11. PubMed ID: 16426921
    [Abstract] [Full Text] [Related]

  • 14. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP, Osório CA, Torres C, Bastos EP, Mourão-Neto M, Soares FA, Brentani HP, Carraro DM.
    Breast Cancer Res; 2008 Feb 15; 10(5):R87. PubMed ID: 18928525
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
    Steinman S, Wang J, Bourne P, Yang Q, Tang P.
    Ann Clin Lab Sci; 2007 Feb 15; 37(2):127-34. PubMed ID: 17522367
    [Abstract] [Full Text] [Related]

  • 17. Genetic analysis of HER-2/neu gene amplification in paraffin embedded tumour tissue in women with breast cancer.
    Zadrozny M, Smolarz B, Romanowicz-Makowska H, Kozłowska E, Kulig A.
    Pol J Pathol; 2002 Feb 15; 53(4):189-93. PubMed ID: 12597335
    [Abstract] [Full Text] [Related]

  • 18. Pathobiologic findings in DCIS of the breast: morphologic features, angiogenesis, HER-2/neu and hormone receptors.
    Claus EB, Chu P, Howe CL, Davison TL, Stern DF, Carter D, DiGiovanna MP.
    Exp Mol Pathol; 2001 Jun 15; 70(3):303-16. PubMed ID: 11418009
    [Abstract] [Full Text] [Related]

  • 19. Intratumoral heterogeneity of her-2/neu in invasive mammary carcinomas using fluorescence in-situ hybridization and tissue microarray.
    Shin SJ, Hyjek E, Early E, Knowles DM.
    Int J Surg Pathol; 2006 Oct 15; 14(4):279-84. PubMed ID: 17041191
    [Abstract] [Full Text] [Related]

  • 20. Patterns of chromosomal alterations in breast ductal carcinoma in situ.
    Hwang ES, DeVries S, Chew KL, Moore DH, Kerlikowske K, Thor A, Ljung BM, Waldman FM.
    Clin Cancer Res; 2004 Aug 01; 10(15):5160-7. PubMed ID: 15297420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.